Reaction Details |
| Report a problem with these data |
Target | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [H1047R] |
---|
Ligand | BDBM618133 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | PI3K-Alpha Kinase (PIK3CA) Activity, Wild-Type and H1047R Mutant and Determining IC50 Values for Inhibitors |
---|
IC50 | <500±n/a nM |
---|
Citation | ANDERSON, ED; ARONOW, SD; BOYLES, NA; DAHLGREN, MK; FENG, S; GERASYUTO, AI; HICKEY, ER; IRVIN, TC; KESICKI, EA; KLIPPEL-GIESE, A; KNIGHT, JL; KOLAKOWSKI, GR; KUMAR, M; LONG, KF; MAYNE, CG; MCELLIGOTT, DL; MCLEAN, JA; PUCA, L; RAVI, KK; SEVERANCE, DL; WELCH, MB; WIDJAJA, T ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE US Patent US20230286960 Publication Date 9/14/2023 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [H1047R] |
---|
Name: | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [H1047R] |
Synonyms: | PIK3CA | PK3CA_HUMAN | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform mutant | Phosphoinositide 3-Kinase (PI3K), alpha Mutant (H1047R) Chain A |
Type: | Catalytic subunit |
Mol. Mass.: | 124314.42 |
Organism: | Homo sapiens (Human) |
Description: | P42336 H1047R |
Residue: | 1068 |
Sequence: | MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQ
LLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFA
IGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKH
IYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLK
LCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMD
CFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGI
YHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHC
PLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWF
SSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPL
SEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAME
LLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTN
QRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILK
QEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLW
LNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLS
IGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRS
CAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDF
LIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIA
YIRKTLALDKTEQEALEYFMKQMNDARHGGWTTKMDWIFHTIKQHALN
|
|
|
BDBM618133 |
---|
n/a |
---|
Name | BDBM618133 |
Synonyms: | 2-[1-[2-(6-Azabicyclo[3.1.1]heptan-6-yl)-6-methyl-4-oxo-chromen-8-yl]ethylamino]benzoic acid | US20230286960, Example 425 |
Type | Small organic molecule |
Emp. Form. | C25H26N2O4 |
Mol. Mass. | 418.4849 |
SMILES | C[C@@H](Nc1ccccc1C(O)=O)c1cc(C)cc2c1oc(cc2=O)N1C2CC1CCC2 |r| |
Structure |
|